Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
RegeneRx Biopharmaceuticals In - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
RGRX
Over the counter
8731
http://www.regenerx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for RegeneRx Biopharmaceuticals In
RegeneRx Effects Reverse Stock Split and Terminates SEC Reporting Obligations
- Aug 15th, 2023 12:00 pm
RegeneRx Receives Stockholder Approval for Reverse Stock Split
- Aug 7th, 2023 8:06 pm
RegeneRx To Extend Consent Solicitation Vote
- Aug 1st, 2023 4:34 pm
First Patient Enrolled into U.S. Phase 3 Neurotrophic Keratitis Clinical Trial with RGN-259
- Apr 13th, 2023 12:04 pm
RegeneRx Issues Letter To Stockholders
- Apr 11th, 2023 8:59 pm
Scroll